sk&f 86002 has been researched along with Idiopathic Parkinson Disease in 1 studies
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iba, M | 1 |
| Kim, C | 1 |
| Kwon, S | 1 |
| Szabo, M | 1 |
| Horan-Portelance, L | 1 |
| Peer, CJ | 1 |
| Figg, WD | 1 |
| Reed, X | 1 |
| Ding, J | 1 |
| Lee, SJ | 1 |
| Rissman, RA | 1 |
| Cookson, MR | 1 |
| Overk, C | 1 |
| Wrasidlo, W | 1 |
| Masliah, E | 1 |
1 other study available for sk&f 86002 and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD.
Topics: alpha-Synuclein; Animals; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Neuro | 2023 |